Patent 10136816 was granted and assigned to Abbott on November, 2018 by the United States Patent and Trademark Office.
Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.